NEW YORK, April 9, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Charles River Laboratories International, Inc. (“Charles River” or the “Company”) CRL. Those investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, extension 7980.

The investigation concerns whether Charles River and certain of its officers and/or directors have engaged in securities fraud or other illegal business practices.

[Click here for information about joining the class action]

On February 22, 2023, Charles River announced it had received a subpoena from the US Department of Justice regarding an investigation into the company’s alleged illegal transportation of primates for research purposes. Charles River said it would voluntarily stop importing primates from Cambodia, acknowledging that the investigations and suspension of imports would negatively impact its business.

As a result of this news, Charles River’s share price fell $24.51 per share, or 10.06%, to close at $219.09 per share on February 22, 2023.

The Pomerantz law firm, with offices in New York, Chicago, Los Angeles, London and Paris, is recognized as one of the leading law firms in the areas of corporate, securities and antitrust litigation. Founded by the late Abraham L. Pomerantz, known as Dean of the Class Attorney’s Association, the Pomerantz firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz law firm continues the tradition he established and fights for the rights of victims of securities fraud, breaches of fiduciary duty and corporate misconduct. The firm has recovered numerous multi-million dollar claims on behalf of group members. See www.pomerantzlaw.com.

CONTACT:

Robert S Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com
888-476-6529 extension 798